WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

SOCIOPSYCOLOGICAL IMPACTS AFFECTING PATIENTS WITH CHRONIC KIDNEY DISEASE

Abdullah Ali Alkhathami* and Oliyan Shoqer Al-Rashedy, Dr. Qazi Imtiaz, Dr. Mohammed Al-Mansour, Dr. Waqas Sami, Dr. Ezzat and Dr. Eman

ABSTRACT

Background: Chronic kidney disease (CKD) is a progressive, lifethreatening illness characterized by losing renal function over period of time (months, years), posing a fundamental existential problem on individuals and a burden on their families. Due to the life–long illness, majority of CKD patients may trigger physiologic, psychological, and social stressors at any point during the disease, thus, placing a barrier for them in maintaining the normal life-style and may also reduce their quality of life. Objectives: The present study has been designed to find out the prevalence of depression among CKD patients in central region of KSA and to evaluate their social life, personal relationships & quality of life. Material & Methods: It was an observational cross –sectional Hospital based study. The data was collected from 33 CKD patients of either sex from Haemodialysis units at King Khalid Hospital, Almajmaah and Hurameula General Hospital, Hurameula, Kingdom of Saudi Arabia. A pre-defined self validated questionnaire (Beck Depression Inventory) was used to measure the severity of depression. To evaluate the Quality of Life of CKD, WHOQOL questionnaire was adapted and modified to the current situation. Results: The prevalence of depression among CKD patients was 44.0%. Majority of the patients had depression at the beginning of the condition 29 (90.6%), About 3/4 of the patients 24 (75.0%) were leading normal social life despite of being diseased. Significant association was observed between depression scale and depression at the beginning of the condition (p=0.43), showing that majority of the patients had borderline depression (n=8, 27.6%), (n=7, 24.1%) had moderate depression, whereas, (n=6, 20.7%) had severe depression. Significant association was observed between depression scale and the QoL scale (p<0.001), showing that those with acceptable quality of life had borderline depression (n=9, 33.3%) and those with not acceptable quality of life, majority of them had severe depression (n=4, 80%). Conclusion: A high proportion of CKD patients experienced depression eventually resulting in an impaired quality of life.

Keywords: Chronic kidney disease self validated questionnaire quality of life.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More